HK-listed firm moots Chinese tech board IPO
Shanghai Fudan-Zhangjian Bio-Pharmaceutical Co has become the first Hong Kong-listed company to announce that it wants to float on China’s hotly-anticipated technology board.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts